Walter Lau Wa To
Direktor/Vorstandsmitglied bei Birdie Biotech, Inc.
Profil
Walter Lau Wa To currently works at Oriengene Biotechnology Ltd., as Director, Birdie Biotech, Inc., as Director, Huapu Biotechnology Co., Ltd., as Director, Curegenix, Inc., as Director, and Start Shanghai Co., Ltd., as Director.
Dr. Wa To also formerly worked at Taiwan Liposome Co., Ltd., as Independent Director.
Dr. Wa To received his undergraduate degree from California Institute of Technology and doctorate degree from the University of California, Berkeley.
Aktive Positionen von Walter Lau Wa To
| Unternehmen | Position | Beginn |
|---|---|---|
Birdie Biotech, Inc.
 Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - |
| Huapu Biotechnology Co., Ltd. | Direktor/Vorstandsmitglied | - |
Oriengene Biotechnology Ltd.
 Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Direktor/Vorstandsmitglied | - |
| Curegenix, Inc. | Direktor/Vorstandsmitglied | - |
| Start Shanghai Co., Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Walter Lau Wa To
| Unternehmen | Position | Ende |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Walter Lau Wa To
| University of California, Berkeley | Doctorate Degree |
| California Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Birdie Biotech, Inc.
Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Health Technology |
| Huapu Biotechnology Co., Ltd. | |
Oriengene Biotechnology Ltd.
Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Health Technology |
| Curegenix, Inc. | |
| Start Shanghai Co., Ltd. |
